:: KONGPOSH Publications - Did You Know ::

HOME CONTACT BACK

FROM THE DESK OF THE EDITOR-IN-CHIEF

CURRENT ISSUE

As the year 2011 draws to an end, the ‘Aam Admi’ has one bright spot on the horizon – a beginning in the fight against corruption in our country. Public anger is largely apparent, corrupt politicians and officials are beginning to be jailed and a sound Jan Lok Pal is on the way. It’s a long crusade which can only succeed with the combined and sustained efforts of our 1.2 billion people.
At a time when the global pharma industry which is valued at around 875 billion USD, is facing its biggest challenge of increasing costs of healthcare and low yields on R&D expenditure, our pharma industry continues to be India’s top science based industries growing at around 9% annually. It is estimated to be valued at 55 billion USD in 2020. Ranked 3rd in the world in terms of volume, and with ‘Advantage India’ – competent workforce, cost effective chemical synthesis, good legal and financial framework, IT, globalization and consolidation, our industry is set for unprecedented growth.
The rapid advancement of biotechnology in India in recent years is another feather in India’s science based industries. Drug discovery, tissue engineering, gene transplantation and biogenerics are some of the areas of huge potential growth. Club this with the scope of new drug discovery from our own pool of traditional alternative systems of medicines; we have the ideal environment to produce newer, cheaper and effective medicines and therapies.
As in tune with previous years, this annual issue comes along with a special advertising supplement to be distributed at P-Mec/CPhI expo in Mumbai, IPC in Bangalore and Nepal Pharma in Kathmandu. The journal has grown from strength to strength over the years and this year the journal was listed in the prestigious ULRICH'S Database for the quality of its content. That’s a direct acknowledgement of our esteemed contributors, advertisers, readers and well wishers, to whom we express our deepest gratitude.
2012 will hold many challenges, more competition for us all. Indian pharmaceutical industry is optimistic on its growth prospects and it seems that the “EUROZONE” crisis and the deepening of the financial turmoil in the US have not dampened the sentiments of this sector. The policy makers are ready with the right strategic moves to achieve growth. Similarly, we too at Kongposh publications are well prepared to explore the new changing landscape. Like we say – There are journals. And there are journals. And there are more journals. And then there is………..The Pharma Review – Leading through Innovation.
Wishing everyone a Happy and Prosperous 2012.